MCGIVNEY MARK C 4
4 · MARSH & MCLENNAN COMPANIES, INC. · Filed Aug 6, 2024
Insider Transaction Report
Form 4
MCGIVNEY MARK C
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2024-08-02$118.86/sh+10,265$1,220,149→ 43,943 total - Sale
Common Stock
2024-08-02$225.77/sh−3,791$855,880→ 40,152 total - Sale
Common Stock
2024-08-02$226.75/sh−6,074$1,377,305→ 34,078 total - Sale
Common Stock
2024-08-02$227.31/sh−400$90,923→ 33,678 total - Exercise/Conversion
Common Stock
2024-08-05$118.86/sh+5,200$618,098→ 38,878 total - Sale
Common Stock
2024-08-05$225.03/sh−5,200$1,170,156→ 33,678 total - Exercise/Conversion
Stock Options (Right to Buy)
2024-08-02−10,265→ 56,128 totalExercise: $118.86Exp: 2030-02-18→ Common Stock (10,265 underlying) - Exercise/Conversion
Stock Options (Right to Buy)
2024-08-05−5,200→ 50,928 totalExercise: $118.86Exp: 2030-02-18→ Common Stock (5,200 underlying)
Footnotes (5)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.140 to $226.130. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.210 to $227.190. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.290 to $227.325. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- [F5]These options were granted on February 19, 2020 and vested in four equal annual installments on February 19th of 2021, 2022, 2023 and 2024.